CD274 and neoplasm: In a randomized phase II trial, including a treatment-arm of gemcitabine and nab-paclitaxel combined with PD-1 blockade, analysis of paired pre-treatment and on-treatment biopsies from five patients revealed a numerically decreased percentage of tumor cells expressing PD-L1 in all samples measured during treatment,33 but the impact of chemotherapy could not be assessed.